The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.
Nedim Turan
No relevant relationships to disclose
Faysal Dane
No relevant relationships to disclose
Olcun Umit Unal
No relevant relationships to disclose
Mustafa Benekli
No relevant relationships to disclose
Hasan volkan Kara
No relevant relationships to disclose
Dogan Koca
No relevant relationships to disclose
Ozlem Balvan
No relevant relationships to disclose
Tulay Eren
No relevant relationships to disclose
Didem Tastekin
No relevant relationships to disclose
Erkan Dogan
No relevant relationships to disclose
Kaan Helvaci
No relevant relationships to disclose
Umut Demirci
No relevant relationships to disclose
Veli Berk
No relevant relationships to disclose
Selcuk Cemil Ozturk
No relevant relationships to disclose
Mehmet Kucukoner
No relevant relationships to disclose
Mahmut Gumus
No relevant relationships to disclose
Ilhan Oztop
No relevant relationships to disclose
Ugur Coskun
No relevant relationships to disclose
Ahmet Ozet
No relevant relationships to disclose
Suleyman Buyukberber
No relevant relationships to disclose